✨ Free AI Report
Stevanato Group S.p.A.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Stevanato Group S.p.A.
Company Research

Stevanato Group S.p.A.: Business Overview, Financials & Competitive Analysis

Stevanato Group S.p.A. scores 6/10 on the AskCyborg Cyborg Score (Solid). Well-positioned in high-growth pharma segments with operational leverage potential, but execution risk on capacity ramps and macro headwinds warrant cautious approach. Strong fundamentals with 9% Q3 2025 revenue growth and 47% high-value solutions expansion. However, near-term headwinds include Engineering segment challenges (19% decline), capital intensity pressuring free cash flow.

What is Stevanato Group S.p.A.'s industry? Stevanato Group S.p.A. (stevanatogroup.com) operates in Pharmaceutical Packaging & Drug Delivery Systems. AskCyborg classifies Stevanato Group S.p.A. under Pharmaceutical Packaging & Drug Delivery Systems in its company registry.

Stevanato Group is a global leader in pharmaceutical drug containment, drug delivery, and diagnostic solutions with a 75-year heritage. The company serves biopharma, biotech, and life sciences companies by providing i...

6/ 10Solid

Cyborg Score thesis

Well-positioned in high-growth pharma segments with operational leverage potential, but execution risk on capacity ramps and...

Read the full analyst-debate transcript →
Industry Pharmaceutical Packaging & Drug Delivery Systems
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: September 14, 2026
AI-Verified Research
30+ Page Report

Get the Latest Stevanato Group S.p.A. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Analyst-debate audio for Stevanato Group S.p.A.

AskCyborg analysts argue the bull and bear cases for Stevanato Group S.p.A. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Stevanato Group S.p.A. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below

Stevanato Group S.p.A. Overview

Pro stress-test →

Stevanato Group is a global leader in pharmaceutical drug containment, drug delivery, and diagnostic solutions with a 75-year heritage. The company serves biopharma, biotech, and life sciences companies by providing integrated solutions across the entire drug lifecycle, from development through commercial stages.

Strategic Profile

Pro stress-test →

Stevanato leverages deep expertise in precision glass manufacturing combined with cutting-edge engineering to provide value-added solutions for injectable biologics and biosimilars. The company is strategically positioned around high-value solutions (now representing 49% of revenue), with significant capacity expansion underway at Latina and Fishers facilities to capitalize on growing demand for self-administration and ready-to-use drug platforms.

Competitive Landscape

Pro stress-test →

Stevanato competes in the pharmaceutical packaging and drug delivery ecosystem against specialized competitors including West Pharmaceutical Services (prefillable syringes), SCHOTT Pharma (glass containers), and Pro-Dex (engineering services). Stevanato's competitive advantage lies in its integrated end-to-end portfolio spanning containment, delivery systems, diagnostics, and manufacturing services across multiple segments, allowing customers single-source solutions.

Industry Context

Stevanato Group S.p.A. operates in Pharmaceutical Packaging & Drug Delivery Systems.

Key facts

Founded: 1949 · Headquarters: Piombino Dese, Italy · Revenue: €1.17B · Market cap: $4.37B

What the analysts stress-tested

The top findings that survived the multi-agent debate for Stevanato Group S.p.A..

  • High-value solutions achieving record 49% of Q3 2025 revenue with 47% growth driven by Nexa syringes and EZ-fill vials, signaling successful product mix shift
  • FY2025 guidance of €1.16-1.19B revenue and 43-44% high-value mix indicates management confidence despite tariff and FX headwinds
+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • November 2025Q3 2025 revenue €303.2M (+9% YoY); high-value solutions grew 47%; adjusted EBITDA margin improved 280bps to 25.7%
  • January 2026Strategic collaboration with Datwyler and LTS Device Technologies on large-volume subcutaneous drug delivery for home use
  • +1 moreTrack every material event for Stevanato Group S.p.A. as it happens. Explore monitoring →
Get alerted when Stevanato Group S.p.A. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Prefillable Syringes & Glass PackagingLeading supplier of containment solutions for pharma→Glass ContainersPrecision glass packaging for pharmaceuticals→Engineering ServicesPrecision engineering for medical/pharma devices→

Compare Stevanato Group S.p.A. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Stevanato Group S.p.A. operates in Pharmaceutical Packaging & Drug Delivery Systems. See how the rest of the sector scores on the Cyborg framework.

Browse Pharmaceutical Packaging & Drug Delivery Systems research →
NEW · MCP server

Ask your AI assistant about Stevanato Group S.p.A.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Stevanato Group S.p.A. and its top competitor on Cyborg Score”
“What did Stevanato Group S.p.A. do this quarter?”
“Is Stevanato Group S.p.A. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Stevanato Group S.p.A. do?+
Stevanato Group is a global leader in pharmaceutical drug containment, drug delivery, and diagnostic solutions with a 75-year heritage. The company serves biopharma, biotech, and life sciences companies by providing i...
What is Stevanato Group S.p.A.'s Cyborg Score?+
Stevanato Group S.p.A. has a Cyborg Score of 6/10 (Solid). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Stevanato Group S.p.A.'s main competitors?+
Named competitors include Prefillable Syringes & Glass Packaging, Glass Containers, Engineering Services. The full competitive landscape is in the AskCyborg report.
How can I get the full Stevanato Group S.p.A. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Stevanato Group S.p.A. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Stevanato Group S.p.A. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.